CP and End Stage Liver Disease: The following pretreatment factors were not significantly related with a decline in posttreatment liver function: ALP, albumin, HGB, CP class, model for end-stage liver disease (MELD) score, BCLC stage, portal vein thrombus at baseline, radioactivity, dose, and bilobar treatment.